반응식
CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[OH:25][C:26]1[CH:27]=[C:28]2[C:32](=[CH:33][CH:34]=1)[NH:31][CH:30]=[C:29]2[CH2:35][C:36]([OH:38])=O.CCN(C(C)C)C(C)C.[F:48][C:49]1[CH:50]=[C:51]([CH2:56][CH:57]([C:59]2[N:60]=[CH:61][S:62][C:63]=2[C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][C:65]=2[CH3:70])[NH2:58])[CH:52]=[C:53]([F:55])[CH:54]=1>CN(C=O)C>[F:48][C:49]1[CH:50]=[C:51]([CH2:56][CH:57]([NH:58][C:36](=[O:38])[CH2:35][C:29]2[C:28]3[C:32](=[CH:33][CH:34]=[C:26]([OH:25])[CH:27]=3)[NH:31][CH:30]=2)[C:59]2[N:60]=[CH:61][S:62][C:63]=2[C:64]2[CH:69]=[CH:68][CH:67]=[CH:66][C:65]=2[CH3:70])[CH:52]=[C:53]([F:55])[CH:54]=1참가 물질
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
HATU (40 mg, 0.105 mmol) was added to a solution of 2-(5-hydroxy-1H-indol-3-yl)acetic acid (19.2 mg, 0.1 mmol) and DIPEA (0.02 mL, 0.12 mmol) in DMF (0.3 mL). After 10 minutes, 13D (33.1 mg, 0.1 mmol) in 0.2 mL of DMF was added to the reaction. The reaction was stirred for 2 hours. LC/MS shows desired product. Purified reaction mixture on prep reverse phase HPLC using 20-80% B over 20 min. (A=0.1% TFA/H2O; B=0.1% TFA/Acetonitrile). Combined pure fractions as determined by LC/MS and lyophilized to provide the desired product. 1H NMR (400 MHz, DMSO) δ 10.46 (s, 1H), 9.18 (s, 1H), 8.31 (d, J=8.2 Hz, 1H), 7.35-7.15 (m, 2H), 7.05 (t, J=7.1 Hz, 2H), 6.94 (dd, J=10.2, 5.8 Hz, 2H), 6.75 (t, J=7.2 Hz, 2H), 6.59-6.35 (m, 3H), 3.38 (s, 2H), 3.01 (d, J=7.5 Hz, 2H), 1.81 (s, 3H). MS (m/z) 504 [M+H]+.
출처 및 근거
- ORD 기록
- ord-bcb53f6eb1a444eeb1d93a335032e621
- 출처 데이터셋
- uspto-grants-2015_12
- 특허 번호
- US09220710B2
연결된 노트
불러오는 중…